Publication:
A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting from Turkbio registry

Simple item page
dc.contributor.authorYazici, A.
dc.contributor.authorIsik, O. Ozdemir
dc.contributor.authorKoca, S. S.
dc.contributor.authorSenel, S.
dc.contributor.authorInanc, N.
dc.contributor.authorAkar, S.
dc.contributor.authorYilmaz, S.
dc.contributor.authorGunduz, O. Soysal
dc.contributor.authorCefle, A.
dc.contributor.authorOnen, F.
dc.contributor.buuauthorDalkilic, E.
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.buuauthorPehlivan, Y.
dc.contributor.departmentTıp Fakültesi
dc.contributor.orcid0000-0003-2167-4509
dc.contributor.orcid0000-0002-3835-466X
dc.contributor.orcid0000-0002-3734-1242
dc.contributor.orcid0000-0002-6341-2622
dc.contributor.researcheridJBI-6627-2023
dc.contributor.researcheridAAT-3636-2020
dc.contributor.researcheridHTP-6798-2023
dc.contributor.researcheridAAA-8970-2021
dc.contributor.researcheridHJY-2666-2023
dc.contributor.researcheridJDV-5142-2023
dc.date.accessioned2024-06-26T07:03:37Z
dc.date.available2024-06-26T07:03:37Z
dc.date.issued2021-06-01
dc.descriptionBu çalışma, 02-05 Haziran 2021 tarihleri arasında düzenlenen Annual European Congress of Rheumatology (EULAR)’da bildiri olarak sunulmuştur.
dc.identifier.doi10.1136/annrheumdis-2021-eular.2928
dc.identifier.endpage1141
dc.identifier.issn0003-4967
dc.identifier.issueSupplement 1
dc.identifier.startpage1140
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2021-eular.2928
dc.identifier.urihttps://hdl.handle.net/11452/42398
dc.identifier.volume80
dc.identifier.wos000692625300229
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.journalAnnals Of The Rheumatic Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.subjectRheumatology
dc.titleA national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting from Turkbio registry
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication.latestForDiscovery1613225c-2f43-4052-9f82-210c854edcf4

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dalkılıç_vd_2021.pdf
Size:
278.23 KB
Format:
Adobe Portable Document Format
Download

Collections

Yeni Yayınlar